ClinicalTrials.gg
RecruitingNCT06796582Updated Oct 22, 2026

Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors

An observational study in Heart Failure, Coronary Heart Disease (CHD) and Atrial Fibrillation (AF), sponsored by Technical University of Munich. Recruiting at 1 site in Germany. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Technical University of Munich · Observational

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Updated Oct 22, 2026Now RecruitingFirst site in Germany+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
50
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 600 studies in Heart Failure with a site in Germany — 105 open to participants now, 136 under way, 19 of them phase 3. Heart Failure · Germany.

Planned enrollment
175th of 212
50 · median 286
Started
2025
with 28 others
Observational
212 of 600
47 open now
Primary completion
2027-02
later than 58 of 135 live
Registered
546th of 600
by date

Among the 600 studies in Heart Failure with a site in Germany, this one is the 175th largest by planned enrollment of the 212 observational ones that give a count, is one of 29 that started in 2025, is one of 212 observational ones, reaches primary completion later than 58 of the 135 other live ones, and was the 546th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

105 of the 600 studies in Heart Failure with a site in Germany are open now. Recruiting first, the newest first:

100 more — sign in →

All 105 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 600 studies in Heart Failure with a site in Germany, or all of them as a file.
02

Study summary

Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).

03

Conditions studied

  • Heart Failure
  • Coronary Heart Disease (CHD)
  • Atrial Fibrillation (AF)
  • Diabetes Mellitus
  • Arterial Hypertension

Keywords

  • resistance training
  • cardiovascular disease
  • cardiovascular risk factors
  • muscle strength
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who visit the outpatient clinic for Preventive Sports Medicine and Sports Cardiology at the TUM University Hospital, Munich, Germany

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 50 years
  • At least one of the following cardiovascular diseases / risk factors:
  • Heart failure
  • Coronary heart disease
  • Atrial fibrillation
  • Arterial hypertension
  • Type 2 diabetes mellitus
  • Clinically stable for ≥ 4 weeks
  • Medical clearance to perform resistance training / strength testing
  • Signed written

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Acute infection
  • Chronic joint inflammation
  • Knee, hip, ankle, wrist, elbow or shoulder pain
  • Known osteoporosis (T-value ≤ -2.5)
  • Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic)
  • Known cerebral or thoracic aneurysm
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Estimated 1-Repetition-Maximum

    The estimated 1-Repetition-Maximums based on two Multiple-Repetition-Maximum tests with different weight will be compared using Bland-Altman plots. Acceptable Limits of Agreement are defined as +/- 10%. The comparisons will be performed using different published formulas to evaluate, which formula(s) may be recommended in patients with cardiovascular disease / risk factors. The study will be performed on the following resistance training machines: leg press and chest press

    Time frame: cross-sectional study (day 1)

Secondary outcomes

  1. Number of repetitions required to perform a valid Multiple-Repetition-Maximum test

    The Multiple-Repetition-Maximum test is considered valid if muscular failure occurs after completion of 2-10 repetitions. This is based on the evidence that (most) published formulas become less precise if \>10 repetitions can be performed.

    Time frame: cross-sectional (day 1)

  2. Adverse Events

    any adverse events that occur in relation to the Multiple-Repetition-Maximum Tests will be documented

    Time frame: cross-sectional (day 1)

07

Study locations

1 of 1 sites recruiting
  • Department for Preventive Sports Medicine and Sports Cardiology, TUM Klinikum Rechts der Isar, Technical University of Munich
    München, 80809, Germany
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data sharing will depend on the possibility to anonymize the requested data set and must be approved by the data security department of the TUM University Hospital

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jul 2025 (actual). Primary completion is estimated for Feb 2027, 19 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: start Feb 2025 → Jul 2025, primary completion Jun 2025 → Feb 2027 and completion Jun 2025 → Feb 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2025
First posted
Jan 28, 2025
StartActual
Jul 14, 2025was Feb 2025
Primary completionEst.
Feb 2027was Jun 2025
CompletionEst.
Feb 2027was Jun 2025
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 22, 2026
Sites
1 site added — first site in Germany
Show site
  • Department for Preventive Sports Medicine and Sports Cardiology, TUM Klinikum Rechts der Isar, Technical University of Munich · München, Germany
Oct 22, 2026
Start date
Feb 2025→Jul 14, 2025 (actual)
Oct 22, 2026
Primary completion
Jun 2025→Feb 2027
Oct 22, 2026
Study completion
Jun 2025→Feb 2027
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Germany
    Show site
    • Department for Preventive Sports Medicine and Sports Cardiology, TUM Klinikum Rechts der Isar, Technical University of Munich · München, Germany
    Start date Feb 2025→Jul 14, 2025 (now actual)
    Primary completion Jun 2025→Feb 2027
    Study completion Jun 2025→Feb 2027
    + 4 other changes: identifiers, verification date, oversight details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06796582
Responsible party
Stephan Mueller (Exercise Physiologist (Postdoctoral Researcher), Technical University of Munich) — Principal investigator
First posted
Jan 28, 2025
Start date
Jul 14, 2025
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Stephan Mueller, Dr rer nat
Contact
stephan.mueller@mri.tum.de
+49 (0)89 289 24494
Stephan Mueller, Dr rer nat
principal investigator · Technical University of Munich, Department for Preventive Sports Medicine and Sports Cardiology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion